Probi Overview

  • Founded
  • 1991
  • Status
  • Public
  • Employees
  • 178
  • Stock Symbol
  • PROB
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $46.88
  • (As of Monday Closing)

Probi General Information


Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientifically proven health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. Its segments are Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the US , Sweden, EMEA, excluding Sweden, and APAC.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • Sölvegatan 41A
  • 223 70 Lund
  • Sweden
+46 046-286 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Probi Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$46.88 $49.21 $35.53 - $76.73 $561M 11.4M 2.21K $0.96

Probi Financials Summary

In Thousands,
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 809,487 568,425 251,588 450,534
Revenue 82,565 77,781 66,205 69,430
EBITDA 22,425 21,094 19,343 17,960
Net Income 10,885 10,053 9,081 8,763
Total Assets 153,444 151,150 137,931 134,549
Total Debt 7,272 5,418 6,542 13,181
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Probi Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Probi‘s full profile, request access.

Request a free trial

Probi Executive Team (7)

Name Title Board Seat Contact Info
Ole Andersen Chief Executive Officer
Tom Ronnlund Chief Executive Officer
Niklas Bjärum Vice President America and President Probi USA
Jorn Andreas Chief Financial Officer
Niklas Brandt Chief Information Officer and Investor Relations
You’re viewing 5 of 7 executive team members. Get the full list »

Probi Board Members (1)

Name Representing Role Since
Jean-Yves Parisot Probi Chairman 000 0000
To view Probi’s complete board members history, request access »

Probi Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Probi Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Probi‘s full profile, request access.

Request a free trial

Probi Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 06-Jul-2021 0000 000 Biotechnology 000 00000000
00000 000000000 20-Oct-2020 000000000 000 Pharmaceuticals 000 00000000
0000000 24-Mar-2020 00000 0000000 Biotechnology 000 00000000
Nutraceutix 03-Oct-2016 Merger/Acquisition 00000 Other Devices and Supplies 00000 000000000
To view Probi’s complete investments and acquisitions history, request access »

Probi Subsidiaries (1)

Company Name Industry Location Founded
00000000000 Other Devices and Supplies Redmond, WA 0000
To view Probi’s complete subsidiaries history, request access »